Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Multitarget HD-tDCS and Spatial Navigation Memory in Schizophrenia (HD-tDCS-SCZ)

Effects of Multitarget High-Definition Transcranial Direct Current Stimulation and Learning Strategy on Spatial Navigation Memory in Patients With Schizophrenia: A Randomized Sham-Controlled Study

This study investigated whether multitarget high-definition transcranial direct current stimulation (HD-tDCS), combined with cognitive learning strategies, could improve temporal order memory during spatial navigation in patients with schizophrenia.

Schizophrenia is frequently associated with cognitive impairments, including difficulties remembering the order of events and navigating unfamiliar environments. This study examined whether noninvasive electrical brain stimulation could enhance the benefits of repeated memory testing compared with repeated studying.

In this randomized, single-blind, sham-controlled study, 59 hospitalized patients with schizophrenia were assigned to receive either active or sham HD-tDCS while completing a spatial navigation learning task. Both groups performed forward-testing and restudy conditions. Active stimulation was delivered for 20 minutes, and spatial navigation learning lasted approximately 45 minutes.

Spatial navigation memory was evaluated using landmark-order recall accuracy. Resting-state functional near-infrared spectroscopy (fNIRS) was performed before and after the intervention to examine changes in functional connectivity between prefrontal and parietal brain regions.

The study aimed to determine whether multitarget HD-tDCS could improve spatial navigation memory, enhance the benefits of forward testing, and influence functional connectivity in brain networks involved in cognitive control and spatial attention.

Panoramica dello studio

Descrizione dettagliata

  1. Background and Rationale:

    Cognitive impairment is a core feature of schizophrenia and contributes to difficulties in daily functioning. Temporal order memory, which refers to the ability to remember the sequence of events, plays an important role in spatial navigation and the organization of everyday experiences. Patients with schizophrenia frequently demonstrate impairments in temporal processing, episodic memory, and spatial navigation.

    The dorsolateral prefrontal cortex (DLPFC) and inferior parietal lobule (IPL) are involved in cognitive control, working memory, spatial attention, and contextual updating. Altered functional interactions between these regions may contribute to cognitive difficulties in schizophrenia.

    High-definition transcranial direct current stimulation (HD-tDCS) is a noninvasive brain stimulation technique that can modulate cortical activity. Multitarget HD-tDCS may influence multiple cortical regions involved in distributed cognitive networks. Combining brain stimulation with cognitive strategies may provide an approach to improving memory performance.

    Forward testing is a learning strategy in which previously studied information is tested before subsequent information is learned. This strategy may facilitate new learning by reducing interference and improving contextual differentiation. The present study investigated whether multitarget HD-tDCS could enhance the effects of forward testing on spatial navigation memory.

  2. Study Design

    This study used a randomized, single-blind, sham-controlled, parallel-group design. Sixty hospitalized patients diagnosed with schizophrenia according to DSM-5 criteria were assigned to either an active HD-tDCS group or a sham stimulation group, with 30 participants allocated to each group.

    Both groups completed the same spatial navigation learning task, including forward-testing and restudy conditions.

  3. Intervention:

    Multitarget HD-tDCS was administered using a Starstim 32 stimulation system (Neuroelectrics, Spain). Stimulation was directed toward dorsolateral prefrontal and parietal cortical regions.

    Participants in the active stimulation group received 2.0 mA stimulation for 20 minutes while performing the spatial navigation learning task. Participants in the sham group underwent the same electrode setup but received only brief current stimulation periods at the beginning and end of the session.

  4. Spatial Navigation Task:

    Participants completed a spatial navigation task involving four routes presented in video format. The task included two learning strategies.

    In the forward-testing condition, participants completed interim memory tests after studying route information. In the restudy condition, participants repeatedly studied route information without equivalent interim testing.

    Route materials and presentation order were counterbalanced across conditions. Spatial navigation performance was assessed using landmark-order recall accuracy during the final route test.

  5. Neuroimaging Assessment:

    Resting-state functional near-infrared spectroscopy (fNIRS) was used to investigate changes in cortical functional connectivity associated with the intervention.

    Eight-minute resting-state fNIRS recordings were obtained before and after the spatial navigation task. The recordings measured changes in oxygenated and deoxygenated hemoglobin concentrations.

    Functional connectivity was estimated between regions associated with the DLPFC and IPL. Changes in functional connectivity were examined to explore potential relationships between brain network activity and spatial navigation performance.

  6. Study Objectives:

The study investigated whether multitarget HD-tDCS combined with cognitive learning strategies could influence immediate temporal order memory during spatial navigation in patients with schizophrenia.

Additional objectives included examining intervention-related changes in resting-state frontoparietal functional connectivity and exploring associations between connectivity measures, cognitive performance, and clinical characteristics.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

60

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Gansu
      • Lanzhou, Gansu, Cina
        • The Third People's Hospital of Lanzhou

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 17 anni a 62 anni (Bambino, Adulto)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Duration of illness of at least 1 year.

Predominantly negative symptoms based on clinical assessment.

Total Positive and Negative Syndrome Scale (PANSS) score greater than 70.

Stable antipsychotic medication for at least 8 weeks.

Montreal Cognitive Assessment (MoCA) score between 10 and 26.

Exclusion Criteria:

  • Substance abuse, excluding caffeine and tobacco use.

Presence of other psychiatric disorders.

Contraindications to transcranial electrical stimulation, including intracranial implants or a history of epilepsy.

Pregnancy or breastfeeding.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Active Multitarget HD-tDCS

Participants received active multitarget high-definition transcranial direct current stimulation (HD-tDCS) at 2.0 mA for 20 minutes while completing spatial navigation learning tasks involving forward-testing and restudy conditions.

Multitarget high-definition transcranial direct current stimulation was administered using a Starstim 32 system (Neuroelectrics, Spain). Active stimulation was delivered at 2.0 mA for 20 minutes, concurrently with spatial navigation learning tasks. Stimulation targeted dorsolateral prefrontal and parietal cortical regions.

Comparatore fittizio: Sham HD-tDCS

Participants received sham HD-tDCS using the same electrode montage as the active group, with brief current delivery and approximately 30-second ramping periods at the beginning and end of stimulation, without sustained stimulation. Participants completed the same spatial navigation learning tasks involving forward-testing and restudy conditions.

Sham stimulation was administered using the same Starstim 32 system and electrode montage as the active-stimulation condition. Brief current application, including approximately 30-second ramping periods at the beginning and end of the session, was used without sustained stimulation. Participants performed the same spatial navigation learning tasks as those in the active-stimulation group.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Landmark-Order Recall Accuracy
Lasso di tempo: Immediately following the spatial navigation learning task (approximately 45 minutes after task initiation).

Landmark-order recall accuracy was assessed during the final test of the spatial navigation task under forward-testing and restudy learning conditions. Accuracy was calculated as the proportion of correctly recalled landmark-order information, with scores ranging from 0 to 1. Higher scores indicate better temporal order memory performance.

Immediately following the spatial navigation learning task (approximately 45 minutes after task initiation).

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Resting-State DLPFC-IPL Functional Connectivity (HbO)
Lasso di tempo: Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).

Resting-state functional connectivity between dorsolateral prefrontal cortex (DLPFC)-associated and inferior parietal lobule (IPL)-associated regions was assessed using functional near-infrared spectroscopy (fNIRS). Pearson correlation coefficients between predefined regions of interest were Fisher z-transformed and averaged. The outcome was calculated as post-intervention minus pre-intervention connectivity using oxygenated hemoglobin (HbO) signals.

Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).
Change in Resting-State DLPFC-IPL Functional Connectivity (HbR)
Lasso di tempo: Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).

Resting-state functional connectivity between dorsolateral prefrontal cortex (DLPFC)-associated and inferior parietal lobule (IPL)-associated regions was assessed using functional near-infrared spectroscopy (fNIRS). Pearson correlation coefficients between predefined regions of interest were Fisher z-transformed and averaged. The outcome was calculated as post-intervention minus pre-intervention connectivity using deoxygenated hemoglobin (HbR) signals.

Baseline and immediately after the intervention (8-minute resting-state recordings at each assessment).

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Wenxi Su, PhD, School of Psychology, Northwest Normal University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

9 gennaio 2026

Completamento primario (Effettivo)

20 maggio 2026

Completamento dello studio (Effettivo)

31 maggio 2026

Date di iscrizione allo studio

Primo inviato

10 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

10 novembre 2026

Primo Inserito (Effettivo)

16 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

16 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 20261008
  • 32560207 (Altro numero di sovvenzione/finanziamento: National Natural Science Foundation of China)
  • 2026CXZX-272 (Altro numero di sovvenzione/finanziamento: Gansu Provincial University Graduate Innovation Star Project)
  • GSJKKY2025-19 (Altro numero di sovvenzione/finanziamento: Gansu Provincial Disease Prevention and Control Research Program)
  • GSWSQN2025-25 (Altro numero di sovvenzione/finanziamento: Gansu Provincial Health Research Project)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be shared because the dataset contains sensitive psychiatric and clinical information. The study team has no current plan to make individual-level data available to external researchers.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi